Dr. Taenzler earned his doctorate in experimental neuropsychology from Clark University in 1995, where he served as an associate professor and departmental statistical consultant for various universities in the Boston area. He has worked as a research consultant in the pharmaceutical and biotechnology industry for more than 20 years, including Executive Vice President in a large, global marketing research company (GfK) and Founder/Principal in two custom research organizations (Evolution Consulting & Research and Jaunty Consulting).
Dr. Taenzler has conducted global pharma/biotech research in over 30 countries and is well-versed in the healthcare regulatory issues and government agencies that provide and oversee healthcare services. Dr. Taenzler has conducted research in nearly every area of healthcare including:
Early marketing involvement in the clinical program can give a customer perspective that is vital to a clinical program’s design via marketing research before and during clinical trials, marketers can help R&D address end-user needs and be financially savvy.
Devices that deliver innovative drugs well can lift a product to blockbuster status. Success, however, requires early involvement of device manufacturers in the drug-development process.
Product managers searching for information and insights in product development and marketing planning are increasingly turning to a pharmaceutical marketing research method, called patient experience or treatment mapping, as a key source of "fact-based" background information.
Customers have questions, you have answers. Display the most frequently asked questions, so everybody benefits.